Proxximos Limited secures £25k for hospital infection control software

Digital tools designed to track and prevent the spread of infectious diseases in hospitals are the focus of Proxximos Limited, which has just closed a £25k funding round. Based in Sevenoaks, the company reached an estimated post-money valuation of £2.1m following this latest investment.

Proxximos Limited was incorporated in February 2025 to provide digital information and resources for protecting workplaces and communities from communicable diseases. Its initial product is specifically tailored for infection prevention and control within the healthcare sector and is currently undergoing pilot testing in hospitals.

The company operates with a small team, reporting two employees in its latest accounts for the year ended 28 February 2026. This recent £25k injection (allotted in March 2026) follows several funding events during the previous year. In November 2025, Proxximos Limited raised £120.4k at a valuation of £2.2m, alongside a separate £50k round at a £2m valuation. Prior to those, the firm secured £50k in October 2025 at a £2m valuation and £200k in September 2025 at a £1.9m valuation.

The current valuation of £2.1m indicates a slight adjustment from the £2.2m high reached in late 2025, though it remains above the valuations seen in the company's earliest rounds. The documentation for this latest capital increase was filed in May 2026.